Mortality outcomes and economic burden of antimicrobial-resistant bacterial bloodstream infections in a Nigerian tertiary hospital
BMC Microbiology · 2026
DOI: 10.1186/s12866-026-05348-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2026. Verfasst von Babatunde Akinola und 29 weiteren Autor:innen. Beteiligte Einrichtung: Management Sciences for Health, 8 Sakete Street, Wuse 11, Abuja, Nigeria. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Bacteremia, Bacteria. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UK Department of Health and Social Care (DHSC) through the Fleming Fund using UK aid.
Abstract (Originalsprache)
BACKGROUND: Antimicrobial resistance (AMR) poses a global public health and economic challenge, significantly contributing to poor outcomes of bacteria bloodstream infections (BSI). There is a paucity of local data on outcomes of AMR BSIs in Nigeria. This prospective cohort study determined outcomes and healthcare costs of BSIs stratified by resistance status. METHOD: Data were prospectively collected from enrolled participants (neonates, children and adults) with susceptible (cohort 1) and resistant (cohort 2) BSIs caused by Enterobacterales, Pseudomonas spp, Acinetobacter spp., Staphylococcus aureus, and Enterococcus spp, and a control group without BSI (cohort 3), at the University of Port Harcourt Teaching Hospital between April and November 2025. Outcomes (in-hospital mortality and extra length of hospital stay, LOS) were compared between the three cohorts using time-dependent and multi-state regression models that adjusted for patients' characteristics, time-varying cofounders and competing risks, while healthcare costs were compared using Students' t' test and analysis of variance. RESULTS: A total of 952 patients were recruited, with 330 neonates, 271 children and 351 adults. The overall prevalence of bacteria-confirmed BSI was 18.1%, with neonatal BSI of 27.3%, childhood BSI of 12.5% and adult BSI of 13.7% (p < 0.0001). In-hospital mortality was higher for healthcare onset (HO) compared to community onset (CO) BSI (sdHR:1.7 (0.65-4.5)], MRSA compared to MSSA BSI [sdHR: 4.1 (0.49-33.5)], and clindamycin-resistant compared to clindamycin-susceptible S. aureus BSI (sdHR: 6.8 (0.36-129.4)]. Multistate modelling showed that HO-BSI caused extra LOS of 2.28 days compared to CO-BSI, resistant BSI caused extra LOS of 1.72 days compared to susceptible BSI, MRSA-BSI caused extra LOS of 2.83 days compared to MSSA-BSI, and ESBL-BSI caused extra LOS of 4.28 days compared to non-ESBL-BSIs. Healthcare costs, catastrophic expenditures and impoverishment from out-of-pocket spending were high for all groups but generally higher for patients with HO and resistant BSIs. CONCLUSION: Compared to susceptible bacterial BSIs, resistant bacterial BSIs are associated with higher mortality, extra length of hospital stays and excess healthcare costs. Policies to reduce the burden of resistant BSIs should focus on improving infection prevention and control and antimicrobial stewardship practices in both hospital settings and the community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Management Sciences for Health, 8 Sakete Street, Wuse 11, Abuja, Nigeria.
- Management Sciences for Health, 8 Sakete Street, Wuse 11, Abuja, Nigeria. Ifyforedu@yahoo.com.
- Department of Medical Microbiology, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria. Ifyforedu@yahoo.com.
- Nigeria Centre for Disease Control, Abuja, Nigeria.
- Department of Medical Microbiology and Parasitology, University of Port Harcourt Teaching Hospital, Port Harcourt, River State, Nigeria.
- Department of Community Medicine, Federal Teaching Hospital, Owerri, Imo State, Nigeria.
Förderung
- UK Department of Health and Social Care (DHSC) through the Fleming Fund using UK aid
Zitieren
APA
Akinola, B., Nwafia, I., Onwuliri, C., Ekechi, H., Abdullahi, K., Adedoyin, J., Osuocha, C., Okache, W., Bellonwu, V., Udah, D., Malgwi, S., Abdulkarim, A., Oyebade, M., Kwange, D., Gbolade, A., Dauda, I., Gbogboade, O., Mmadu-Okoli, C., Ayandipo, E., …, & Idris, J. (2026). Mortality outcomes and economic burden of antimicrobial-resistant bacterial bloodstream infections in a Nigerian tertiary hospital. BMC Microbiology. https://doi.org/10.1186/s12866-026-05348-2
Vancouver
Akinola B, Nwafia I, Onwuliri C, Ekechi H, Abdullahi K, Adedoyin J, et al. Mortality outcomes and economic burden of antimicrobial-resistant bacterial bloodstream infections in a Nigerian tertiary hospital. BMC Microbiology. 2026. doi:10.1186/s12866-026-05348-2
BibTeX
@article{Akinola2026,
author = {Akinola, Babatunde and Nwafia, Ifeyinwa and Onwuliri, Chinemerem and Ekechi, Henry and Abdullahi, Kabir and Adedoyin, John and Osuocha, Calista and Okache, Winifred and Bellonwu, Vivian and Udah, Donald and Malgwi, Sunday and Abdulkarim, Ahmed and Oyebade, Marian and Kwange, Dooshima and Gbolade, Adetomiwa and Dauda, Ibrahim and Gbogboade, Oluchukwu and Mmadu-Okoli, Chidindu and Ayandipo, Esther and Akpaka, Agatha and Salifu, Charles and Alex-Wele, Mary and Nwokoro, Ugochukwu and John, Obed and Iliyasu, Dahiru and Taiwo, Samuel and Okwor, Tochi and Yahaya, Ridwan and Ezechukwu, Dozie and Idris, Jide},
title = {Mortality outcomes and economic burden of antimicrobial-resistant bacterial bloodstream infections in a Nigerian tertiary hospital},
journal = {BMC Microbiology},
year = {2026},
doi = {10.1186/s12866-026-05348-2}
}
EUVIMED